![Perry Sternberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perry Sternberg
Director/Board Member at
HARROW, INC.
Net worth: - $ as of 31/08/2026
Profile
Perry J.
Sternberg is currently Chief Executive Officer & Director at Sydnexis, Inc. since 2024, Lead Independent Director at Harrow, Inc. since 2022, and Director at Surface Ophthalmics, Inc. Former positions include President & Chief Executive Officer at Corium LLC (Massachusetts) from 2019 to 2024, Chief Executive Officer at Corium Innovations, Inc., President, Chief Executive Officer & Director at Corium LLC, Head-Neuroscience Business Unit at Shire Plc from 2013 to 2019, and Vice President & General Manager at Bausch & Lomb, Inc. Education includes an undergraduate degree from The Pennsylvania State University, conferred in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HARROW, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Perry Sternberg active positions
| Companies | Position | Start |
|---|---|---|
| HARROW, INC. | Director/Board Member | 31/03/2022 |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Director/Board Member | - |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 01/08/2024 |
Former positions of Perry Sternberg
| Companies | Position | End |
|---|---|---|
| CORIUM INTERNATIONAL INC | Chief Executive Officer | 01/07/2024 |
Corium Pharma Solutions, Inc.
 Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Chief Executive Officer | 17/01/2023 |
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
 Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Corporate Officer/Principal | - |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Chief Executive Officer | - |
Training of Perry Sternberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Health Technology |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
- Stock Market
- Insiders
- Perry Sternberg
